Raph Goldacre
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments
- Amyotrophic Lateral Sclerosis Research
Papers in
-
- COVID-19 Clinical Research Studies 12
-
- Multiple Sclerosis Research Studies 10
- Co-authors
- Michael J Goldacre (45 shared papers)Tiarnán D L Keenan (7 shared papers)Julia Pakpoor (9 shared papers)Sreeram V Ramagopalan (6 shared papers)Kevin Talbot (4 shared papers)Martin R. Turner (4 shared papers)Martin Landray (6 shared papers)Alastair John Noyce (2 shared papers)
- Journals
- The Lancet (9 papers)The Lancet Infectious Diseases (5 papers)Multiple Sclerosis Journal (4 papers)Neurology (4 papers)The Lancet Regional Health - Europe (4 papers)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Raph Goldacre
88 papers receiving 4.4k citations
Raph Goldacre's Hit Papers
Peers
Comparison fields: 5 of 127
- Infectious Diseases 1.5k
- Neurology 531
- Oncology 682
- Applied Microbiology and Biotechnology 41
- Pathology and Forensic Medicine 250
Countries citing papers authored by Raph Goldacre
This map shows the geographic impact of Raph Goldacre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raph Goldacre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raph Goldacre more than expected).
Fields of papers citing papers by Raph Goldacre
This network shows the impact of papers produced by Raph Goldacre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raph Goldacre. The network helps show where Raph Goldacre may publish in the future.
Co-authors
The 25 scholars most cited alongside Raph Goldacre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England Hit paper breakdown → | 2020 | 520 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 3 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 4 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 5 | 2021 | 254 | |
| 6 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 7 | 2021 | 213 | |
| 8 | 2018 | 196 | |
| 9 | 2013 | 153 | |
| 10 | 2018 | 111 | |
| 11 | 2013 | 85 | |
| 12 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 13 | 2014 | 81 | |
| 14 | 2014 | 75 | |
| 15 | 2022 | 63 | |
| 16 | 2014 | 61 | |
| 17 | 2016 | 59 | |
| 18 | 2022 | 55 | |
| 19 | 2016 | 54 | |
| 20 | 2012 | 51 |
About Raph Goldacre
Raph Goldacre is a scholar working on Infectious Diseases, Pathology and Forensic Medicine, Neurology, Pediatrics, Perinatology and Child Health and Ophthalmology, having authored 91 papers that have together received 4.6k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (12 papers), Multiple Sclerosis Research Studies (10 papers), Maternal and fetal healthcare (6 papers), COVID-19 and healthcare impacts (5 papers), Dementia and Cognitive Impairment Research (3 papers), Health disparities and outcomes (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Maternal and Neonatal Healthcare (3 papers). The work is most often cited by research in Infectious Diseases (1.5k citations), Neurology (531 citations), Oncology (682 citations), Applied Microbiology and Biotechnology (41 citations) and Pathology and Forensic Medicine (250 citations). Raph Goldacre has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Michael J Goldacre, Tiarnán D L Keenan, Julia Pakpoor, Sreeram V Ramagopalan, Kevin Talbot, Martin R. Turner, Martin Landray, Alastair John Noyce, Eva J.A. Morris and Thomas T. Warner. Their work appears in journals such as The Lancet, The Lancet Infectious Diseases, Multiple Sclerosis Journal, Neurology and The Lancet Regional Health - Europe.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.